- ALNY has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $54.0 million.
- ALNY has traded 50,336 shares today.
- ALNY is down 4.1% today.
- ALNY was up 7.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ALNY with the Ticky from Trade-Ideas. See the FREE profile for ALNY NOW at Trade-Ideas More details on ALNY: Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Currently there are 4 analysts that rate Alnylam Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Alnylam Pharmaceuticals has been 744,800 shares per day over the past 30 days. Alnylam has a market cap of $7.7 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.17 and a short float of 10.8% with 9.78 days to cover. Shares are up 54.3% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.